Centogene Gross Margin 2019-2023 | CNTG

Current and historical gross margin for Centogene (CNTG) over the last 10 years. The current gross profit margin for Centogene as of June 30, 2023 is %.
Centogene Gross Margin Historical Data
Date TTM Revenue TTM Gross Profit Gross Margin
2022-06-30 $0.11B $0.02B 15.74%
2022-03-31 $0.16B $0.02B 13.92%
2021-12-31 $0.22B $0.03B 15.18%
2021-09-30 $0.26B $0.05B 18.36%
2021-06-30 $0.26B $0.07B 24.81%
2021-03-31 $0.21B $0.06B 27.49%
2020-12-31 $0.15B $0.05B 32.88%
2020-09-30 $0.08B $0.03B 34.18%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.013B $0.050B
Centogene is a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actionable information for patients, physicians and pharmaceutical companies. The Company?s goal is to bring rationality to treatment decisions and to accelerate the development of new orphan drugs by using their knowledge of the global rare disease market, including epidemiological and clinical data and innovative biomarkers.
Stock Name Country Market Cap PE Ratio
GE HealthCare Technologies (GEHC) United States $38.473B 21.40
Inspire Medical Systems (INSP) United States $6.824B 0.00
IRhythm Technologies (IRTC) United States $3.536B 0.00
Axonics (AXNX) United States $3.409B 0.00
10x Genomics (TXG) United States $3.313B 0.00
Enovis (ENOV) United States $3.044B 23.13
Azenta (AZTA) United States $2.839B 231.41
Olink Holding AB (publ) (OLK) Sweden $2.739B 0.00
Hims & Hers Health (HIMS) United States $2.545B 0.00
Privia Health (PRVA) United States $2.142B 95.00
Schrodinger (SDGR) United States $1.771B 0.00
Omnicell (OMCL) United States $1.294B 31.66
Phreesia (PHR) United States $1.264B 0.00
Definitive Healthcare (DH) United States $0.863B 0.00
Standard BioTools (LAB) United States $0.737B 0.00
Fulgent Genetics (FLGT) United States $0.615B 0.00
Talkspace (TALK) United States $0.519B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.327B 0.00
Health Catalyst (HCAT) United States $0.326B 0.00
Clover Health Investments (CLOV) United States $0.308B 0.00
Pulmonx (LUNG) United States $0.285B 0.00
MSP Recovery (LIFW) United States $0.171B 0.00
P3 Health Partners (PIII) United States $0.165B 0.00
American Well (AMWL) United States $0.160B 0.00
Butterfly Network (BFLY) United States $0.150B 0.00
Augmedix (AUGX) United States $0.146B 0.00
Outset Medical (OM) United States $0.121B 0.00
TruBridge (TBRG) United States $0.121B 5.15
111 (YI) China $0.089B 0.00
SHL Telemedicine (SHLT) Israel $0.079B 0.00
Future Health ESG (FHLT) United States $0.068B 0.00
HeartBeam (BEAT) United States $0.053B 0.00
Zepp Health (ZEPP) China $0.052B 0.00
EUDA Health Holdings (EUDA) Singapore $0.043B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.033B 0.00
Movano (MOVE) United States $0.026B 0.00
Cue Health (HLTH) United States $0.022B 0.00
Bullfrog AI Holdings (BFRG) United States $0.022B 0.00
Streamline Health Solutions (STRM) United States $0.020B 0.00
Strata Skin Sciences (SSKN) United States $0.019B 0.00
CareCloud (CCLD) United States $0.018B 0.00
Akili (AKLI) United States $0.018B 0.00
ETAO (ETAO) United States $0.015B 0.00
Biotricity (BTCY) United States $0.014B 0.00
Transgenomic (PRPO) United States $0.009B 0.00
HeartSciences (HSCS) United States $0.007B 0.00
Healthcare Triangle (HCTI) United States $0.006B 0.00
Syra Health (SYRA) United States $0.006B 0.00
Predictive Oncology (POAI) United States $0.005B 0.00
Zhongchao (ZCMD) China $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00